WALPAR Stock Overview
Engages in the manufacture and trading of pharmaceutical, nutraceutical, herbal, and ayurvedic commodities. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Walpar Nutritions Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹48.45 |
| 52 Week High | ₹76.98 |
| 52 Week Low | ₹39.00 |
| Beta | -0.54 |
| 1 Month Change | 5.33% |
| 3 Month Change | -2.61% |
| 1 Year Change | 10.87% |
| 3 Year Change | 239.40% |
| 5 Year Change | n/a |
| Change since IPO | 70.00% |
Recent News & Updates
Walpar Nutritions Limited (NSE:WALPAR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 28
Does Walpar Nutritions (NSE:WALPAR) Deserve A Spot On Your Watchlist?
Sep 07Market Might Still Lack Some Conviction On Walpar Nutritions Limited (NSE:WALPAR) Even After 26% Share Price Boost
Jul 27Recent updates
Walpar Nutritions Limited (NSE:WALPAR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 28Does Walpar Nutritions (NSE:WALPAR) Deserve A Spot On Your Watchlist?
Sep 07Market Might Still Lack Some Conviction On Walpar Nutritions Limited (NSE:WALPAR) Even After 26% Share Price Boost
Jul 27With EPS Growth And More, Walpar Nutritions (NSE:WALPAR) Makes An Interesting Case
Feb 14Here's Why Walpar Nutritions (NSE:WALPAR) Has Caught The Eye Of Investors
Sep 18We Ran A Stock Scan For Earnings Growth And Walpar Nutritions (NSE:WALPAR) Passed With Ease
May 25If EPS Growth Is Important To You, Walpar Nutritions (NSE:WALPAR) Presents An Opportunity
Sep 29Walpar Nutritions Limited's (NSE:WALPAR) P/E Is Still On The Mark Following 26% Share Price Bounce
Jul 22Shareholder Returns
| WALPAR | IN Personal Products | IN Market | |
|---|---|---|---|
| 7D | 1.6% | -2.6% | -4.2% |
| 1Y | 10.9% | -4.9% | 19.1% |
Return vs Industry: WALPAR exceeded the Indian Personal Products industry which returned -4.9% over the past year.
Return vs Market: WALPAR underperformed the Indian Market which returned 19.1% over the past year.
Price Volatility
| WALPAR volatility | |
|---|---|
| WALPAR Average Weekly Movement | 7.9% |
| Personal Products Industry Average Movement | 5.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: WALPAR's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: WALPAR's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Kalpesh Ladhawala | www.walparnutritions.com |
Walpar Nutritions Limited engages in the manufacture and trading of pharmaceutical, nutraceutical, herbal, and ayurvedic commodities. It is also involved in the contract manufacturing of nutraceutical and herbal products; and trading of raw material used in manufacturing nutraceutical products. The company was founded in 2009 and is based in Gandhinagar, India.
Walpar Nutritions Limited Fundamentals Summary
| WALPAR fundamental statistics | |
|---|---|
| Market cap | ₹440.04m |
| Earnings (TTM) | ₹24.73m |
| Revenue (TTM) | ₹643.77m |
17.8x
P/E Ratio0.7x
P/S RatioIs WALPAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WALPAR income statement (TTM) | |
|---|---|
| Revenue | ₹643.77m |
| Cost of Revenue | ₹502.47m |
| Gross Profit | ₹141.30m |
| Other Expenses | ₹116.58m |
| Earnings | ₹24.73m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.72 |
| Gross Margin | 21.95% |
| Net Profit Margin | 3.84% |
| Debt/Equity Ratio | 47.7% |
How did WALPAR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 00:41 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Walpar Nutritions Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|